Purpose: Chromosomal microarray (CMA) testing provides the highest diagnostic yield for clinical testing of patients with developmental delay (DD), intellectual disability (ID), multiple congenital ...

The 2010 consensus statement on diagnostic chromosomal microarray (CMA) testing recommended an array resolution ≥400 kb throughout the genome as a balance of analytical and clinical sensitivity. In ...

Experts have uncovered further evidence that a chromosomal test can boost the chances of success with IVF. Chromosomal abnormalities can cause embryos to fail, even though they may look healthy under ...

New York, NY—A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant ...

While children are known for their active imaginations, it’s extremely rare for them to have true psychotic symptoms. But two unusual case studies, both of children under seven, prompted a new ...

Thermo Fisher Scientific Inc., announced that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

Children are known for their active imaginations, but it’s extremely rare for them to have true psychotic symptoms. A study co-led by Joseph Gonzalez-Heydrich, MD, a psychiatrist at Boston Children’s ...